Effect of cyproterone acetate on clinical, endocrine and pathological features of benign prostatic hypertrophy.
D000135:Acid Phosphatase / Q000378:metabolism; D001120:Arginine / Q000494:pharmacology; D002369:Castration; D002996:Clomiphene / Q000494:pharmacology; D003534:Cyproterone / Q000494:pharmacology / Q000627:therapeutic use*; D004964:Estriol / Q000378:metabolism; D004970:Estrone / Q000378:metabolism; D005965:Glucuronates / Q000652:urine; D006801:Humans; D006984:Hypertrophy / Q000188:drug therapy; D008297:Male; D011467:Prostate / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D011469:Prostatic Diseases / Q000188:drug therapy* / Q000503:physiopathology; D013737:Testis / Q000502:physiology; D013739:Testosterone / Q000378:metabolism
D005965:Glucuronates; D002996:Clomiphene; D004970:Estrone; D013739:Testosterone; D001120:Arginine; D003534:Cyproterone; D000135:Acid Phosphatase; D004964:Estriol